Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use

Autor: Elisabeth García-Muñoz, Joaquim Vives
Přispěvatelé: Institut Català de la Salut, [García-Muñoz E] Banc de Sang i Teixits, 08005 Barcelona, Spain. [Vives J] Banc de Sang i Teixits, 08005 Barcelona, Spain. Grup d'Enginyeria de Teixits Musculoesquelètics, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Clinical Biochemistry
Methods Paper
Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy::Cell Transplantation::Stem Cell Transplantation::Mesenchymal Stem Cell Transplantation [ANALYTICAL
DIAGNOSTIC AND THERAPEUTIC TECHNIQUES
AND EQUIPMENT]

Biomedical Engineering
Adipose tissue
Bioengineering
Sistema nerviós - Degeneració - Tractament
Bioinformatics
Regenerative medicine
03 medical and health sciences
0302 clinical medicine
Wharton's jelly
MSCs isolation protocols
Cèl·lules mare mesenquimàtiques - Ús terapèutic
Medicine
Bone marrow
enfermedades del sistema nervioso::enfermedades neurodegenerativas [ENFERMEDADES]
Umbilical cord
Multipotent mesenchymal stromal cells
Otros calificadores::/terapia [Otros calificadores]
terapéutica::terapia biológica::tratamientos basados en células y tejidos::trasplante de células::trasplante de células madre::trasplante de células madre mesenquimatosas [TÉCNICAS Y EQUIPOS ANALÍTICOS
DIAGNÓSTICOS Y TERAPÉUTICOS]

Wharton’s jelly
business.industry
Mesenchymal stem cell
Tissue Processing
Cell Biology
Other subheadings::/therapy [Other subheadings]
Transplantation
030104 developmental biology
medicine.anatomical_structure
Nervous System Diseases::Neurodegenerative Diseases [DISEASES]
030220 oncology & carcinogenesis
business
Biotechnology
Adult stem cell
Zdroj: Scientia
Cytotechnology
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Popis: Teixit adipós; Medul·la òssia; Cèl·lules estromals mesenquimals multipotents Tejido adiposo; Médula ósea; Células estromales mesenquimales multipotentes Adipose tissue; Bone marrow; Multipotent mesenchymal stromal cells Multipotent mesenchymal stromal cells (MSCs) are currently the most extensively studied type of adult stem cells in advanced stages of development in the field of regenerative medicine. The biological properties of MSCs have generated great hope for their therapeutic use in degenerative and autoimmune conditions that, at present, lack effective treatment options. Over the last decades, MSCs have been typically obtained from adult bone marrow, but the extraction process is highly invasive and the quality and numbers of isolated cells is drastically influenced by patient age, medication and associated comorbidities. Therefore, there is currently an open discussion on the convenience of allogeneic over autologous treatments, despite potential disadvantages such as rejection by the host. This shift to the allogeneic setting entails the need for high production of MSCs to ensure availability of sufficient cell numbers for transplantation, and therefore making the search for alternative tissue sources of highly proliferative MSC cultures with low levels of senescence occurrence, which is one of the greatest current challenges in the scale up of therapeutic cell bioprocessing. Herein we (i) present the main isolation protocols of MSCs from bone marrow, adipose tissue and Wharton’s jelly of the umbilical cord; and (ii) compare their qualities from a bioprocess standpoint, addressing both quality and regulatory aspects, in view of their anticipated clinical use. This work has been developed in the context of the Spanish Cell Therapy Network (TerCel, expedient number: RD16/0011/0028) and project PI19/01788, which is funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF)—A way to build Europe.
Databáze: OpenAIRE